New York, New York (PRWEB) July 22, 2013 -- Stryker lawsuit claims alleging injuries due to Stryker’s recalled Rejuvenate and ABG II Modular Neck Hip Stems continue to move forward in a consolidated proceeding now underway in New Jersey’s Bergen County Superior Court. Court documents indicate that deposition guidelines were issued in the litigation on July 15th that address the need to preserve testimony of witnesses who are in extremis in specific cases that have not been selected for early mediation, advanced discovery or bellwether trials. (In Re Stryker Rejuvenate Hip Stem and the ABG II Modular Hip Stem Litigation, No. 296)
“Our Firm continues to file Stryker lawsuits in this litigation on behalf of clients allegedly injured by Rejuvenate and ABG II hip stems. We are pleased to see the proceeding moving forward,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm continues to offer free legal evaluations to individuals who have allegedly suffered serious complications that may be associated with the Stryker recall.
Stryker Hip Recall
The Stryker recall for Rejuvenate and ABG II hip stems was issued in July 2012, after Stryker determined that the metal components were prone to fretting and corrosion at the modular neck junction.* Court documents indicate that hundreds of Stryker lawsuits have been filed in courts around the country since the Rejuvenate recall was announced. All of the lawsuits allege the hip components caused plaintiffs to suffer a number of serious complications, including metallosis, necrosis and osteolysis. As of July 9th, at least 161 Stryker hip lawsuits were pending in the New Jersey litigation. An additional 159 Stryker hip lawsuits have also been transferred to a multidistrict litigation now underway in U.S. District Court, District of Minnesota. (In re: Stryker Rejuvenate and ABG II Hip Implant Products Liability Litigation, MDL No. 2441)
Since the Stryker recall was announced, the company has warned that recipients of Rejuvenate and ABG II stems may be at risk for adverse local tissue reactions characterized by pain and swelling around the hip joint. Stryker is now advising all patients with the affected implants to undergo medical screening to ensure their hips are functioning properly, regardless of their symptoms.*
Individuals allegedly affected by the Stryker recall for Rejuvenate and ABG II hip stems may be entitled to compensation for medical bills, lost wages, and pain and suffering. Further information regarding Stryker lawsuits is available at Bernstein Liebhard LLP’s website. To learn more, please call 800-511-5092.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
Felecia L. Stern, Stryker Hip Lawsuit Information Center, http://www.stryker-rejuvenate-hip-recall-lawsuit.com, 800-511-5092, [email protected]